Review of Bone Modifying Agents in Metastatic Breast Cancer

Bone is the most common site for distant metastases in breast cancer and can cause significant morbidity and mortality. Bone modifying agents (BMAs) that include bisphosphonates (BPAs) and denosumab help in decreasing and delaying skeletal-related events (SREs) associated with metastatic breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghu Subramanian, Charumathi, Talluri, Swapna, Mullangi, Sanjana, Lekkala, Manidhar R, Moftakhar, Bahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960030/
https://www.ncbi.nlm.nih.gov/pubmed/33738175
http://dx.doi.org/10.7759/cureus.13332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960030/
https://www.ncbi.nlm.nih.gov/pubmed/33738175
http://dx.doi.org/10.7759/cureus.13332

Ejemplares similares